Naltrexone hydrochloride 50 MG Oral Tablet

INDICATIONS AND USAGE Naltrexone Hydrochloride Tablets USP are indicated in the treatment of alcohol dependence and for the blockade of the effects of exogenously administered opioids. Naltrexone Hydrochloride Tablets USP have not been shown to provide any therapeutic benefit except as part of an appropriate plan of management for the addictions.

precision dose inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] diarrhoea` `[5] pain` `[6] off label use` `[7] arthralgia` `[8] vomiting` `[9] headache` `[10] dyspnoea`

4 years ago

ROUND YELLOW EL 15

HOW SUPPLIED

NALTREXONE HYDROCHLORIDE Tablets, USP are available as: 50 mg; yellow, round film-coated tablets, bisected on one side, debossed with "EL" on one side of the bisect and "15" on the other side of the bisect. NDC 68094-853-62 Unit Dose Packages of 30 Tablets (3 × 10) per carton NDC 68094-853-61 Unit Dose Packages of 100 Tablets (10 × 10) per carton NDC 68094-853-66 Unit Dose Packages of 20 Tablets (2 × 10) per carton Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). Protect from light. KEEP THIS AND ALL MEDICATIONS OUT DF THE REACH OF CHILDREN. These are not all the possible side effects of

NALTREXONE HYDROCHLORIDE Tablets, USP. Call your doctor for medical advice about side effects. You may report side effects to Precision Dose, Inc. at 1-800-397-9228 or to FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov.

More pills like ROUND EL 15

Related Pills

elagolix 150 MG Oral Tablet Orilissa

abbvie inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site